We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Univar to Distribute Novozymes' Baking Solutions in Russia
Read MoreHide Full Article
Univar Inc.’s subsidiary, Univar LLC, has announced a deal with Novozymes to expand the geographical scope of its collaboration to add Russia with enzymes for the baking industry.
The agreement provides Univar a platform for expanding into the Russian food and beverage market. Univar sees significant growth potential for the Novozymes portfolio, which will provide innovative process solutions to the baking industry.
Univar stated that it will initially start with developing opportunities for the baking industry within the St. Petersburg and Moscow regions, which represents nearly 50% of the total Russian bakery market.
Also, Univar will focus on improving the quality and freshness of baked goods through the Novozymes Novamyl baking freshness enzyme. The move is in response to the recent Russian government regulations that aims to reduce food waste through retailer incentives.
To improve crumb softness, moistness, mouthfeel and elasticity during storage, Novamyl can be used with buns, bread, rolls as well as lean sweet baked goods in both packaged (or industrial) and artisanal segments.
Univar’s shares have lost 29.6% over a year compared with the 39.5% decline recorded by its industry.
Univar’s adjusted earnings were 42 cents per share in the second quarter, down 10.6% year over year. The figure missed the Zacks Consensus Estimate of 44 cents.
Revenues rose 9% year over year to $2,584.6 million. However, it lagged the Zacks Consensus Estimate of $2,810.2 million.
The company revised its adjusted EBITDA forecast considering lower-than-expected demand for chemicals and ingredients, higher expected net cost synergies from Nexeo and outlook from many supplier partners. It now sees adjusted EBITDA between $725 million and $740 million, compared with its prior view of $740 million and $760 million.
Univar is progressing well with the integration of Nexeo's chemical distribution customers, suppliers and support functions. The company now sees higher cost saving synergies from Nexeo than what it had originally anticipated. It has raised its guidance for annual net synergy from $100 million to $120 million (before tax). Univar expects to achieve $20 million in net synergies this year, higher than the initial expectations of $10 million.
Zacks Rank & Key Picks
Univar currently carries a Zacks Rank #5 (Strong Sell).
Kinross has an expected earnings growth rate of 140% for 2019. The company’s shares have surged 62.3% in the past year.
Alamos Gold has projected earnings growth rate of 280% for the current year. The company’s shares have rallied 55.1% in a year’s time.
Arconic has an estimated earnings growth rate of 42.7% for the current year. Its shares have moved up 23.6% in the past year.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Image: Bigstock
Univar to Distribute Novozymes' Baking Solutions in Russia
Univar Inc.’s subsidiary, Univar LLC, has announced a deal with Novozymes to expand the geographical scope of its collaboration to add Russia with enzymes for the baking industry.
The agreement provides Univar a platform for expanding into the Russian food and beverage market. Univar sees significant growth potential for the Novozymes portfolio, which will provide innovative process solutions to the baking industry.
Univar stated that it will initially start with developing opportunities for the baking industry within the St. Petersburg and Moscow regions, which represents nearly 50% of the total Russian bakery market.
Also, Univar will focus on improving the quality and freshness of baked goods through the Novozymes Novamyl baking freshness enzyme. The move is in response to the recent Russian government regulations that aims to reduce food waste through retailer incentives.
To improve crumb softness, moistness, mouthfeel and elasticity during storage, Novamyl can be used with buns, bread, rolls as well as lean sweet baked goods in both packaged (or industrial) and artisanal segments.
Univar’s shares have lost 29.6% over a year compared with the 39.5% decline recorded by its industry.
Univar’s adjusted earnings were 42 cents per share in the second quarter, down 10.6% year over year. The figure missed the Zacks Consensus Estimate of 44 cents.
Revenues rose 9% year over year to $2,584.6 million. However, it lagged the Zacks Consensus Estimate of $2,810.2 million.
The company revised its adjusted EBITDA forecast considering lower-than-expected demand for chemicals and ingredients, higher expected net cost synergies from Nexeo and outlook from many supplier partners. It now sees adjusted EBITDA between $725 million and $740 million, compared with its prior view of $740 million and $760 million.
Univar is progressing well with the integration of Nexeo's chemical distribution customers, suppliers and support functions. The company now sees higher cost saving synergies from Nexeo than what it had originally anticipated. It has raised its guidance for annual net synergy from $100 million to $120 million (before tax). Univar expects to achieve $20 million in net synergies this year, higher than the initial expectations of $10 million.
Zacks Rank & Key Picks
Univar currently carries a Zacks Rank #5 (Strong Sell).
Some better-ranked stocks in the basic materials space are Kinross Gold Corporation (KGC - Free Report) , Alamos Gold Inc (AGI - Free Report) and Arconic Inc , all sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Kinross has an expected earnings growth rate of 140% for 2019. The company’s shares have surged 62.3% in the past year.
Alamos Gold has projected earnings growth rate of 280% for the current year. The company’s shares have rallied 55.1% in a year’s time.
Arconic has an estimated earnings growth rate of 42.7% for the current year. Its shares have moved up 23.6% in the past year.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>